Nov. 12, 2021– In January 2021, St. Luke’s Health System Senior Director of Pharmacy Scott Milner was the featured guest on 340B Health’s podcast, 340B Insight, to discuss the initial rollout of COVID-19 vaccines throughout the U.S. “For me, the vaccine's greatest side effect is hope,” Scott said at the time. Fast forward 10 months, and much has happened in the national … [Read more...]
Recognizing Patients on 340B’s Anniversary
Nov. 4, 2021 – Jennifer Gallagher was aware of the 340B drug pricing program as the lead pharmacy technician at Parkview Medical Center in Pueblo, Colo. But she says it was not until she had her own medical challenges that she came to understand what the program means to patients. Today she views 340B as playing a pivotal role in her ability to stay healthy and continue working … [Read more...]
Eli Lilly Again Reports Big Revenue Gains From 340B Denials
Nov. 1, 2021– The first drug company to deny 340B drug pricing program discounts to safety-net hospitals, health centers, and clinics saw its U.S. revenues jump 26% in the third quarter of 2021, thanks in part to the higher prices it is charging for diabetes drugs sold to 340B providers. In a public financial report, Eli Lilly said its third-quarter U.S. revenue totaled … [Read more...]
Faces of 340B: Community Pharmacy Partnerships Benefit Patients with Diabetes
Oct. 28, 2021 – Courtney Riddle’s patient was at a family-owned pharmacy in Magnolia, Ark., where she always picked up her medications, including the diabetes drug Jardiance that was helping to control her blood sugar levels. The patient’s out-of-pocket cost typically was $16.43 for a month’s supply, but this time it was much different. The patient received a note that said … [Read more...]
340B Is a Key Element of the Mission Against Breast Cancer
Oct. 22, 2021– Each October, national organizations aim to make more Americans aware of what they can do to prevent and treat breast cancer as well as support people whose lives have been affected by the disease. Breast Cancer Awareness Month also is a time to look at how the 340B drug pricing program can help expand prevention and treatment efforts. Screenings Are … [Read more...]
Federal Report Suggests Another Reason To End 340B Orphan Drug Loophole
Oct. 18, 2021– A new federal government report could add momentum to efforts on Capitol Hill to end limitations on 340B price discounts for orphan drugs purchased by certain safety-net hospitals. The report suggests that drug companies might be seeking orphan status for their products to maximize revenues and avoid paying 340B discounts on drugs widely used to treat common … [Read more...]
Seventh Drug Company Told It is Violating 340B Law
Oct. 12, 2021– Eight drug companies have restricted access to discounts to safety-net providers through the 340B drug pricing program on drugs dispensed at community-based pharmacies. Now the government officially has informed all but one of those companies that they are in violation of federal law and must restore the discounted pricing. The most recent recipient of a … [Read more...]